Literature DB >> 15983550

Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation.

Rie Kojima1, Ukihide Tateishi, Masahiro Kami, Naoko Murashige, Yasuhito Nannya, Eiji Kusumi, Miwa Sakai, Yuji Tanaka, Yoshinobu Kanda, Shin-Ichiro Mori, Shigeru Chiba, Masahiko Kusumoto, Shigesaburo Miyakoshi, Hisamaru Hirai, Shuichi Taniguchi, Hisashi Sakamaki, Yoichi Takaue.   

Abstract

Computed tomography (CT) is a powerful diagnostic tool for invasive aspergillosis (IA) after allogeneic stem cell transplantation (allo-SCT); however, little information is available concerning CT findings of late IA after allo-SCT. To characterize CT findings of late IA, we retrospectively examined medical records and high-resolution CT findings of 27 allo-SCT recipients with late IA. Either acute or chronic GVHD was diagnosed in 24 patients. All 27 patients were given corticosteroids at IA diagnosis. High-resolution CT findings included halo (n=12), centrilobular nodules (n=12), ill-defined consolidation (n=13), ground-glass attenuation (n=8), pleural effusion (n=7), pleural-based consolidation (n=4), and cavitation (n=4). CT findings showing centrilobular nodules and either halo or cavitation were classified into bronchopneumonia type and angioinvasive type, respectively. Angioinvasive-type, bronchopneumonia-type, and combination-type IA were diagnosed in 11, 8, and 4 patients, respectively. CT findings were nonspecific in the other 4 patients. One bronchopneumonia-type case and 2 angioinvasive-type IA cases were subsequently diagnosed as combination type. Although there were no significant differences in patient characteristics between the 2 types of IA, bronchopneumonia-type IA had a poorer prognosis than angioinvasive IA ( P=.022). Halo is a useful diagnostic marker in late IA as well as early IA, and late IA frequently manifests as bronchopneumonia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983550     DOI: 10.1016/j.bbmt.2005.03.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  9 in total

1.  Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.

Authors:  Johan Maertens; Griet Huysmans; Koen Theunissen
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

2.  Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome.

Authors:  Marcio Nucci; Simone A Nouér; Domenico Cappone; Elias Anaissie
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

3.  Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Authors:  D Neofytos; S Treadway; D Ostrander; C D Alonso; K L Dierberg; V Nussenblatt; C M Durand; C B Thompson; K A Marr
Journal:  Transpl Infect Dis       Date:  2013-02-21       Impact factor: 2.228

Review 4.  The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.

Authors:  Sarah P Georgiadou; Nikolaos V Sipsas; Edith M Marom; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 5.  Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.

Authors:  Alisha Y Young; Miguel M Leiva Juarez; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-05-31       Impact factor: 2.878

6.  Infection as a Differential Diagnosis of Solid Retroperitoneal Masses: A Case Series and Review of the Literature.

Authors:  Georgia Levidou; Tilman Klein; Kerstin Schaefer-Eckart; Clemens Huettenbrink; Panagiota Manava
Journal:  Cureus       Date:  2022-05-01

7.  Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.

Authors:  Qidong Zhuang; Hongying Ma; Yun Zhang; Lei Chen; Li Wang; Lin Zheng; Zaichun Deng; Zhongbo Chen
Journal:  Can Respir J       Date:  2017-11-13       Impact factor: 2.409

Review 8.  New Bioengineering Breakthroughs and Enabling Tools in Regenerative Medicine.

Authors:  Alvaro Mata; Helena S Azevedo; Lorenzo Botto; Nuria Gavara; Lei Su
Journal:  Curr Stem Cell Rep       Date:  2017-05-04

9.  Clinical manifestations and outcome analysis of invasive pulmonary aspergillosis infection: a retrospective study in 43 nonneutropenic patients.

Authors:  Lihong Zhang; Chunli Che
Journal:  J Int Med Res       Date:  2019-09-30       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.